Trendium collects top search trends from popular platforms, and leverage AI power to summarize the surrounding public conversation.
Subscribe to our Newsletter to have these hot topics delivered to your inbox every day.
Tell us your feedback here.
Schedule III is a federal drug classification for substances with a moderate to low potential for physical and psychological dependence and an accepted medical use. Moving a drug to this category allows it to be legally prescribed and significantly reduces the tax and regulatory burdens on businesses.
On December 18, 2025, President Trump signed a historic executive order directing the reclassification of marijuana from Schedule I (the most restrictive tier) to Schedule III. This move fulfills a major campaign promise and represents the most significant shift in federal drug policy in over 50 years.
The move is being hailed as a 'wind in the sails' for the medical cannabis industry and a victory for patients suffering from chronic pain and neurological disorders. While some conservative lawmakers remain opposed, the public generally views it as a pragmatic recognition of marijuana's medical benefits that aligns federal law with state-level legalization.